Overview The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females Status: Completed Trial end date: 2006-08-01 Target enrollment: Participant gender: Summary The purpose of this study is the examine the effect of taking exenatide on the blood levels (pharmacokinetics) of orally-administered contraceptives. Phase: Phase 1 Details Lead Sponsor: AstraZenecaCollaborator: Eli Lilly and CompanyTreatments: Contraceptive AgentsContraceptives, OralEstradiolEstradiol 17 beta-cypionateEstradiol 3-benzoateEstradiol valerateEthinyl EstradiolExenatideLevonorgestrelPolyestradiol phosphate